Deferoxamine to Prevent Delayed Cerebral Ischemia After Subarachnoid Hemorrhage

Terminated

Phase 0 Results N/A

Summary of Purpose

The investigators will test the central hypothesis that DFO treatment after SAH may improve cerebrovascular regulation, mitigate ischemic neural injury, and serve as an effective neuroprotectant against delayed ischemic injury after SAH. Trial Stopped: Principle Investigator is moving to another institution and plans to restart this proctocol in the new location.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 17 July 2015.

1 Sep 2014 6 Aug 2014 1 Jun 2015 1 Jul 2015 1 Jul 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Farzaneh A Sorond, MD, PhD